中财网 中财网股票行情
博瑞医药(688166)财务分析指标    年份：
截止日期2025-03-312024-12-312024-09-302024-06-302024-03-31
营业总收入(万元)24895.98128255.1697682.5765768.8434013.31
营业收入(万元)24895.98128255.1697682.5765768.8434013.31
营业总成本(万元)26656.00110259.8779833.9456386.3826734.12
营业成本(万元)13955.3054495.0841024.1529401.7014569.41
净利润(万元)1288.9615133.3614233.807122.816178.48
归属于母公司的净利润(万元)1295.9818916.6917740.8810636.476406.99
营业利润(万元)-1189.6416028.9016835.099439.727069.17
利润总额(万元)-1186.3915720.0616807.639430.637058.70
少数股东损益(万元)-1761.65-4790.37-3065.12-2413.77-226.01
基本每股收益(元)0.03(元)0.45(元)0.42(元)0.25(元)0.15(元)
稀释每股收益(元)0.03(元)0.45(元)0.42(元)0.25(元)0.15(元)
非经常性损益(万元)--865.94--112.85-14.45
扣除非经常性损益后净利润(万元)803.3818050.7517362.5810523.626421.44
总资产(万元)528527.33516434.62487853.28523066.82508750.69
总负债(万元)266925.64272697.03253619.31281652.52261334.18
归属于母公司股东权益合计(万元)250161.88239464.76235238.11238766.25242745.71
股东权益合计(万元)261601.69243737.59234233.97241414.29247416.51
实收资本(股本)(万元)42246.6642246.6642246.6642246.6642246.66
资本公积(万元)107644.4798236.3094938.19105548.31105713.31
未分配利润(万元)97379.9096083.9296732.6389628.2389450.94
经营活动产生的现金流量净额(万元)10699.3024555.9311958.9715122.0314846.18
经营活动现金流入小计(万元)31790.72111787.0690402.3363939.6537572.30
经营活动现金流出小计(万元)21091.4287231.1378443.3648817.6222726.12
投资活动产生的现金流量净额(万元)-22729.76-44014.15-42487.31-29174.57-13837.87
投资活动现金流入小计(万元)0.6215584.169828.198766.95--
投资活动现金流出小计(万元)22730.3859598.3152315.5037941.5213837.87
筹资活动产生的现金流量净额(万元)16939.10-2447.49-17376.7111569.34-1097.14
筹资活动现金流入小计(万元)51815.1992607.7159596.2851606.2826294.66
筹资活动现金流出小计(万元)34876.0995055.2076972.9940036.9427391.80
期末现金及现金等价物余额(万元)80631.1375410.1949332.4094812.2797096.19
最后修改日期2025-04-172025-04-032024-10-302024-08-262024-04-27
↑返回页顶↑

转至博瑞医药（688166）行情首页

中财网免费提供股票、基金、债券、外汇、理财等行情数据以及其他资料，仅供用户获取信息。